 | • レポートコード：QY20ST-09719 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の合成ポリペプチド薬市場について種類別（遺伝子デリバリー、ドラッグデリバリー、バイオイメージング、組織エンジニアリング、抗菌薬、その他）、用途別（Gene Delivery、 Drug Delivery、 Bio-Imaging、 Tissue Engineering、 Antimicrobials、 Other）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・合成ポリペプチド薬市場の概要 ・世界の主要地域別合成ポリペプチド薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の合成ポリペプチド薬市場規模2015-2026：種類別（遺伝子デリバリー、ドラッグデリバリー、バイオイメージング、組織エンジニアリング、抗菌薬、その他） ・世界の合成ポリペプチド薬市場規模2015-2026：用途別（Gene Delivery、 Drug Delivery、 Bio-Imaging、 Tissue Engineering、 Antimicrobials、 Other） ・合成ポリペプチド薬の北米市場規模2015-2020 ・合成ポリペプチド薬のヨーロッパ市場規模2015-2020 ・合成ポリペプチド薬の中国市場規模2015-2020 ・合成ポリペプチド薬の日本市場規模2015-2020 ・合成ポリペプチド薬の東南アジア市場規模2015-2020 ・合成ポリペプチド薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・合成ポリペプチド薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・合成ポリペプチド薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Synthesis Polypeptide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Synthesis Polypeptide Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Polypeptide synthesis is the biological production of peptides, which are organic compounds in which multiple amino acids are linked via peptide bonds.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Synthesis Polypeptide Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Synthesis Polypeptide Drugs industry.
Based on our recent survey, we have several different scenarios about the Synthesis Polypeptide Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Synthesis Polypeptide Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Synthesis Polypeptide Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Synthesis Polypeptide Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Synthesis Polypeptide Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Synthesis Polypeptide Drugs market. The report also includes nautical information, where it shows Synthesis Polypeptide Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Synthesis Polypeptide Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Synthesis Polypeptide Drugs market.
Geographical Analysis:
Based on region, the global Synthesis Polypeptide Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Synthesis Polypeptide Drugs market are
Novartis
Thermo Fisher Scientific
Merck Millipore
Ferring Pharmaceuticals
AstraZeneca
HYBIO Pharmaceutical
Hainan Zhonghe Pharmaceutical
PolyPeptide
Abzena
CPC Scientific
Segment by Type
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug (hCG)
Urinary System Drug (Diabetes Insipidus)
Other
Segment by Application
Gene Delivery
Drug Delivery
Bio-Imaging
Tissue Engineering
Antimicrobials
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Synthesis Polypeptide Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Synthesis Polypeptide Drugs market.
• The market share of the global Synthesis Polypeptide Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Synthesis Polypeptide Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Synthesis Polypeptide Drugs market.
1 Synthesis Polypeptide Drugs Market Overview
1.1 Synthesis Polypeptide Drugs Product Scope
1.2 Synthesis Polypeptide Drugs Segment by Type
1.2.1 Global Synthesis Polypeptide Drugs Sales by Type (2020-2026)
1.2.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.2.3 Digestive System Drugs (Gastrointestinal Type)
1.2.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.2.5 Gynecologic or Obstetric Drug
1.2.6 Tumor Drug (hCG)
1.2.7 Urinary System Drug (Diabetes Insipidus)
1.2.8 Other
1.3 Synthesis Polypeptide Drugs Segment by Application
1.3.1 Global Synthesis Polypeptide Drugs Sales Comparison by Application (2020-2026)
1.3.2 Gene Delivery
1.3.3 Drug Delivery
1.3.4 Bio-Imaging
1.3.5 Tissue Engineering
1.3.6 Antimicrobials
1.3.7 Other
1.4 Synthesis Polypeptide Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Synthesis Polypeptide Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Synthesis Polypeptide Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Synthesis Polypeptide Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Synthesis Polypeptide Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Synthesis Polypeptide Drugs Industry
1.5.1.1 Synthesis Polypeptide Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Synthesis Polypeptide Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Synthesis Polypeptide Drugs Players to Combat Covid-19 Impact
2 Synthesis Polypeptide Drugs Estimate and Forecast by Region
2.1 Global Synthesis Polypeptide Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Synthesis Polypeptide Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Synthesis Polypeptide Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Synthesis Polypeptide Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Synthesis Polypeptide Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Synthesis Polypeptide Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Synthesis Polypeptide Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Synthesis Polypeptide Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Synthesis Polypeptide Drugs Estimates and Projections (2015-2026)
2.4.3 China Synthesis Polypeptide Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Synthesis Polypeptide Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Synthesis Polypeptide Drugs Estimates and Projections (2015-2026)
2.4.6 India Synthesis Polypeptide Drugs Estimates and Projections (2015-2026)
3 Global Synthesis Polypeptide Drugs Competition Landscape by Players
3.1 Global Top Synthesis Polypeptide Drugs Players by Sales (2015-2020)
3.2 Global Top Synthesis Polypeptide Drugs Players by Revenue (2015-2020)
3.3 Global Synthesis Polypeptide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthesis Polypeptide Drugs as of 2019)
3.4 Global Synthesis Polypeptide Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Synthesis Polypeptide Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Synthesis Polypeptide Drugs Players (Opinion Leaders)
4 Global Synthesis Polypeptide Drugs Market Size by Type
4.1 Global Synthesis Polypeptide Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Synthesis Polypeptide Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Synthesis Polypeptide Drugs Price by Type (2014-2020)
4.2 Global Synthesis Polypeptide Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Synthesis Polypeptide Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Synthesis Polypeptide Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Synthesis Polypeptide Drugs Price Forecast by Type (2021-2026)
5 Global Synthesis Polypeptide Drugs Market Size by Application
5.1 Global Synthesis Polypeptide Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Synthesis Polypeptide Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Synthesis Polypeptide Drugs Price by Application (2015-2020)
5.2 Global Synthesis Polypeptide Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Synthesis Polypeptide Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Synthesis Polypeptide Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Synthesis Polypeptide Drugs Price Forecast by Application (2021-2026)
3 North America Synthesis Polypeptide Drugs Market Facts & Figures
3.2 North America Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
3.3 North America Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
3.4 North America Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
4 Europe Synthesis Polypeptide Drugs Market Facts & Figures
4.2 Europe Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
5 China Synthesis Polypeptide Drugs Market Facts & Figures
5.2 China Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
5.3 China Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
5.4 China Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
6 Japan Synthesis Polypeptide Drugs Market Facts & Figures
6.2 Japan Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Synthesis Polypeptide Drugs Market Facts & Figures
7.2 Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
8 India Synthesis Polypeptide Drugs Market Facts & Figures
8.2 India Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
8.3 India Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
8.4 India Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Synthesis Polypeptide Drugs Business
12.1 Novartis
12.1.1 Novartis Synthesis Polypeptide Drugs Corporation Information
12.1.2 Novartis Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.1.3 Novartis Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis Synthesis Polypeptide Drugs Products Offered
12.1.5 Novartis Recent Development
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Synthesis Polypeptide Drugs Corporation Information
12.2.2 Thermo Fisher Scientific Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.2.3 Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Thermo Fisher Scientific Synthesis Polypeptide Drugs Products Offered
12.2.5 Thermo Fisher Scientific Recent Development
12.3 Merck Millipore
12.3.1 Merck Millipore Synthesis Polypeptide Drugs Corporation Information
12.3.2 Merck Millipore Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.3.3 Merck Millipore Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Merck Millipore Synthesis Polypeptide Drugs Products Offered
12.3.5 Merck Millipore Recent Development
12.4 Ferring Pharmaceuticals
12.4.1 Ferring Pharmaceuticals Synthesis Polypeptide Drugs Corporation Information
12.4.2 Ferring Pharmaceuticals Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.4.3 Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ferring Pharmaceuticals Synthesis Polypeptide Drugs Products Offered
12.4.5 Ferring Pharmaceuticals Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Synthesis Polypeptide Drugs Corporation Information
12.5.2 AstraZeneca Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.5.3 AstraZeneca Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AstraZeneca Synthesis Polypeptide Drugs Products Offered
12.5.5 AstraZeneca Recent Development
12.6 HYBIO Pharmaceutical
12.6.1 HYBIO Pharmaceutical Synthesis Polypeptide Drugs Corporation Information
12.6.2 HYBIO Pharmaceutical Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.6.3 HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 HYBIO Pharmaceutical Synthesis Polypeptide Drugs Products Offered
12.6.5 HYBIO Pharmaceutical Recent Development
12.7 Hainan Zhonghe Pharmaceutical
12.7.1 Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Corporation Information
12.7.2 Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.7.3 Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Products Offered
12.7.5 Hainan Zhonghe Pharmaceutical Recent Development
12.8 PolyPeptide
12.8.1 PolyPeptide Synthesis Polypeptide Drugs Corporation Information
12.8.2 PolyPeptide Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.8.3 PolyPeptide Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 PolyPeptide Synthesis Polypeptide Drugs Products Offered
12.8.5 PolyPeptide Recent Development
12.9 Abzena
12.9.1 Abzena Synthesis Polypeptide Drugs Corporation Information
12.9.2 Abzena Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.9.3 Abzena Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Abzena Synthesis Polypeptide Drugs Products Offered
12.9.5 Abzena Recent Development
12.10 CPC Scientific
12.10.1 CPC Scientific Synthesis Polypeptide Drugs Corporation Information
12.10.2 CPC Scientific Synthesis Polypeptide Drugs Business Overview and Total Revenue
12.10.3 CPC Scientific Synthesis Polypeptide Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CPC Scientific Synthesis Polypeptide Drugs Products Offered
12.10.5 CPC Scientific Recent Development
13 Synthesis Polypeptide Drugs Manufacturing Cost Analysis
13.1 Synthesis Polypeptide Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Synthesis Polypeptide Drugs
13.4 Synthesis Polypeptide Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Synthesis Polypeptide Drugs Distributors List
14.3 Synthesis Polypeptide Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Synthesis Polypeptide Drugs Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Synthesis Polypeptide Drugs Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Synthesis Polypeptide Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Synthesis Polypeptide Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Synthesis Polypeptide Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Synthesis Polypeptide Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Synthesis Polypeptide Drugs Sales (MT) by Region (2015-2020)
Table 10. Global Synthesis Polypeptide Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Synthesis Polypeptide Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Synthesis Polypeptide Drugs Revenue Share by Region (2015-2020)
Table 13. Global Synthesis Polypeptide Drugs Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Synthesis Polypeptide Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Synthesis Polypeptide Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Synthesis Polypeptide Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Synthesis Polypeptide Drugs (MT) of Key Companies (2015-2020)
Table 18. Global Synthesis Polypeptide Drugs Sales Share by Company (2015-2020)
Table 19. Global Synthesis Polypeptide Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Synthesis Polypeptide Drugs Revenue Share by Company (2015-2020)
Table 21. Global Synthesis Polypeptide Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synthesis Polypeptide Drugs as of 2019)
Table 22. Global Synthesis Polypeptide Drugs Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Synthesis Polypeptide Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Synthesis Polypeptide Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Synthesis Polypeptide Drugs Players
Table 27. Global Synthesis Polypeptide Drugs Sales (MT) by Type (2015-2020)
Table 28. Global Synthesis Polypeptide Drugs Sales Share by Type (2015-2020)
Table 29. Global Synthesis Polypeptide Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Synthesis Polypeptide Drugs Price (MT) by Type (2015-2020)
Table 31. Global Synthesis Polypeptide Drugs Sales Share by Type (2021-2026)
Table 32. Global Synthesis Polypeptide Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Synthesis Polypeptide Drugs Revenue Share by Type (2021-2026)
Table 34. Global Synthesis Polypeptide Drugs Price (MT) by Type (2021-2026)
Table 35. Global Synthesis Polypeptide Drugs Sales (MT) by Application (2015-2020)
Table 36. Global Synthesis Polypeptide Drugs Sales Share by Application (2015-2020)
Table 37. Global Synthesis Polypeptide Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Synthesis Polypeptide Drugs Price (MT) by Application (2015-2020)
Table 39. Global Synthesis Polypeptide Drugs Sales (MT) by Application (2021-2026)
Table 40. Global Synthesis Polypeptide Drugs Sales Share by Application (2021-2026)
Table 41. Global Synthesis Polypeptide Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Synthesis Polypeptide Drugs Revenue Share by Application (2021-2026)
Table 43. Global Synthesis Polypeptide Drugs Price (MT) by Application (2021-2026)
Table 44. United States Synthesis Polypeptide Drugs Sales (MT) by Company (2015-2020)
Table 45. United States Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Synthesis Polypeptide Drugs Sales (MT) by Type (2015-2020)
Table 47. United States Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Synthesis Polypeptide Drugs Sales (MT) by Application (2015-2020)
Table 49. United States Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Synthesis Polypeptide Drugs Sales (MT) by Company (2015-2020)
Table 51. Europe Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Synthesis Polypeptide Drugs Sales (MT) by Type (2015-2020)
Table 53. Europe Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Synthesis Polypeptide Drugs Sales (MT) by Application (2015-2020)
Table 55. Europe Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 56. China Synthesis Polypeptide Drugs Sales (MT) by Company (2015-2020)
Table 57. China Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
Table 58. China Synthesis Polypeptide Drugs Sales (MT) by Type (2015-2020)
Table 59. China Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 60. China Synthesis Polypeptide Drugs Sales (MT) by Application (2015-2020)
Table 61. China Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Synthesis Polypeptide Drugs Sales (MT) by Company (2015-2020)
Table 63. Japan Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Synthesis Polypeptide Drugs Sales (MT) by Type (2015-2020)
Table 65. Japan Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Synthesis Polypeptide Drugs Sales (MT) by Application (2015-2020)
Table 67. Japan Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Synthesis Polypeptide Drugs Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Synthesis Polypeptide Drugs Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Synthesis Polypeptide Drugs Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 74. India Synthesis Polypeptide Drugs Sales (MT) by Company (2015-2020)
Table 75. India Synthesis Polypeptide Drugs Sales Market Share by Company (2015-2020)
Table 76. India Synthesis Polypeptide Drugs Sales (MT) by Type (2015-2020)
Table 77. India Synthesis Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 78. India Synthesis Polypeptide Drugs Sales (MT) by Application (2015-2020)
Table 79. India Synthesis Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Novartis Synthesis Polypeptide Drugs Product
Table 84. Novartis Recent Development
Table 85. Thermo Fisher Scientific Corporation Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Thermo Fisher Scientific Synthesis Polypeptide Drugs Product
Table 89. Thermo Fisher Scientific Recent Development
Table 90. Merck Millipore Corporation Information
Table 91. Merck Millipore Description and Business Overview
Table 92. Merck Millipore Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Merck Millipore Synthesis Polypeptide Drugs Product
Table 94. Merck Millipore Recent Development
Table 95. Ferring Pharmaceuticals Corporation Information
Table 96. Ferring Pharmaceuticals Description and Business Overview
Table 97. Ferring Pharmaceuticals Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Ferring Pharmaceuticals Synthesis Polypeptide Drugs Product
Table 99. Ferring Pharmaceuticals Recent Development
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. AstraZeneca Synthesis Polypeptide Drugs Product
Table 104. AstraZeneca Recent Development
Table 105. HYBIO Pharmaceutical Corporation Information
Table 106. HYBIO Pharmaceutical Description and Business Overview
Table 107. HYBIO Pharmaceutical Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. HYBIO Pharmaceutical Synthesis Polypeptide Drugs Product
Table 109. HYBIO Pharmaceutical Recent Development
Table 110. Hainan Zhonghe Pharmaceutical Corporation Information
Table 111. Hainan Zhonghe Pharmaceutical Description and Business Overview
Table 112. Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Hainan Zhonghe Pharmaceutical Synthesis Polypeptide Drugs Product
Table 114. Hainan Zhonghe Pharmaceutical Recent Development
Table 115. PolyPeptide Corporation Information
Table 116. PolyPeptide Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. PolyPeptide Description and Business Overview
Table 118. PolyPeptide Synthesis Polypeptide Drugs Product
Table 119. PolyPeptide Recent Development
Table 120. Abzena Corporation Information
Table 121. Abzena Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Abzena Description and Business Overview
Table 123. Abzena Synthesis Polypeptide Drugs Product
Table 124. Abzena Recent Development
Table . CPC Scientific Corporation Information
Table . CPC Scientific Description and Business Overview
Table . CPC Scientific Synthesis Polypeptide Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . CPC Scientific Synthesis Polypeptide Drugs Product
Table . CPC Scientific Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Synthesis Polypeptide Drugs Distributors List
Table 133. Synthesis Polypeptide Drugs Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Synthesis Polypeptide Drugs Product Picture
Figure 2. Global Synthesis Polypeptide Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Synthesis Polypeptide Drugs Market Share by Application in 2020 & 2026
Figure 6. Gene Delivery Examples
Figure 7. Drug Delivery Examples
Figure 8. Bio-Imaging Examples
Figure 9. Tissue Engineering Examples
Figure 10. Antimicrobials Examples
Figure 11. Other Examples
Figure 12. Global Synthesis Polypeptide Drugs Sales (MT) Growth Rate (2015-2026)
Figure 13. Global Synthesis Polypeptide Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 14. Global Synthesis Polypeptide Drugs Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 15. Global Synthesis Polypeptide Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 16. Global Synthesis Polypeptide Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 17. United States Synthesis Polypeptide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. United States Synthesis Polypeptide Drugs Sales (MT) Growth Rate (2015-2026)
Figure 19. Europe Synthesis Polypeptide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Europe Synthesis Polypeptide Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. China Synthesis Polypeptide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. China Synthesis Polypeptide Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 23. Japan Synthesis Polypeptide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Japan Synthesis Polypeptide Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Synthesis Polypeptide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Synthesis Polypeptide Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 27. India Synthesis Polypeptide Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. India Synthesis Polypeptide Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 29. Global 5 Largest Synthesis Polypeptide Drugs Players Market Share by Revenue in Synthesis Polypeptide Drugs 2015 & 2019
Figure 30. Synthesis Polypeptide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Synthesis Polypeptide Drugs Revenue Share by Type (2015-2020)
Figure 32. Global Synthesis Polypeptide Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 33. Global Synthesis Polypeptide Drugs Revenue Share by Application (2015-2020)
Figure 34. Global Synthesis Polypeptide Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 35. United States Synthesis Polypeptide Drugs Sales Market Share by Type in 2019
Figure 36. United States Synthesis Polypeptide Drugs Sales Market Share by Type in 2019
Figure 37. Europe Synthesis Polypeptide Drugs Sales Market Share by Company in 2019
Figure 38. Europe Synthesis Polypeptide Drugs Sales Market Share by Type in 2019
Figure 39. Europe Synthesis Polypeptide Drugs Sales Market Share by Application in 2019
Figure 40. China Synthesis Polypeptide Drugs Sales Market Share by Company in 2019
Figure 41. China Synthesis Polypeptide Drugs Sales Market Share by Type in 2019
Figure 42. China Synthesis Polypeptide Drugs Sales Market Share by Application in 2019
Figure 43. Japan Synthesis Polypeptide Drugs Sales Market Share by Company in 2019
Figure 44. Japan Synthesis Polypeptide Drugs Sales Market Share by Type in 2019
Figure 45. Japan Synthesis Polypeptide Drugs Sales Market Share by Application in 2019
Figure 46. Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Company in 2019
Figure 47. Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Type in 2019
Figure 48. Southeast Asia Synthesis Polypeptide Drugs Sales Market Share by Application in 2019
Figure 49. India Synthesis Polypeptide Drugs Sales Market Share by Company in 2019
Figure 50. India Synthesis Polypeptide Drugs Sales Market Share by Type in 2019
Figure 51. India Synthesis Polypeptide Drugs Sales Market Share by Application in 2019
Figure 52. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merck Millipore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Ferring Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. HYBIO Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Hainan Zhonghe Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. PolyPeptide Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Abzena Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. CPC Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Key Raw Materials Price Trend
Figure 63. Manufacturing Cost Structure of Synthesis Polypeptide Drugs
Figure 64. Manufacturing Process Analysis of Synthesis Polypeptide Drugs
Figure 65. Synthesis Polypeptide Drugs Industrial Chain Analysis
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. Porter's Five Forces Analysis
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
ポリペプチド薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Polypeptide Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Polypeptide Drug market repo…- 抗腫瘍薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-tumor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 眼感染症治療薬の世界市場レポート2020 A recently published report by QY Research titled Global Eye Infection Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurat…
- 眼感染症治療薬の世界市場レポート2020 A recently published report by QY Research titled Global Eye Infection Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurat…
- 代謝薬物の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Metabolism Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…